Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 24 October 2025

MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI Stock’s Wild Ride: +42% Rally on Major Deal, –50% Crash After $14M Funding

MultiSensor AI (NASDAQ: MSAI) – Shares skyrocketed in late October 2025 and then plunged, reflecting news-driven swings. On Oct. 23 the stock jumped (roughly +42–100%) after the company announced a major U.S. deployment deal ts2.tech. By Oct. 24 it fell nearly 50% when MSAI revealed a $14 million private share placement at $0.409 per share newsfilecorp.com reuters.com. As of Oct. 24 midday, MSAI trades near $0.73 reuters.com (down ~47% on the day and about 32% below its price a year ago tipranks.com). Key fundamentals are modest: full-year 2024 revenue was $7.4 M (2023: $5.4 M) with a net loss of $21.5 M ts2.tech. Q2
24 October 2025
···
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Key Facts: – Neuphoria (Nasdaq: NEUP) shares plunged ~67% in after-hours trading on Oct 20 when its lead drug BNC210 failed a Phase 3 SAD trial Investing. The AFFIRM-1 trial missed both primary and secondary endpoints, and the company immediately halted its social anxiety program and launched a full strategic review Investing Globenewswire. – CEO Spyros Papapetropoulos vowed to “conserve our cash position” while exploring options to “maximize value for shareholders” Globenewswire. Neuphoria will evaluate BNC210 in PTSD (where earlier data were promising) and otherwise cut spending. – NEUP stock fell from about $15.40 on Oct 20 to roughly $5
24 October 2025
Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Picard Medical Stock Plummets 75% on Dilution Alert — What’s Driving the Crash?

Stock Price & Recent Movement Picard Medical stock has been extremely volatile this month. After its Aug. 29 IPO at $4.00, PMI traded mostly under $10, but shot higher in mid-October. On Oct. 20 the stock closed around $11.60, then hit a new 52-week peak near $13.68 by Oct. 23stockanalysis.com. However, on Oct. 24 trading opened sharply lower. By mid-day Oct. 24 the shares were about $3.30, erasing nearly all the prior week’s gainsinvesting.com. Investing.com confirms that as of Oct. 24, 2025 PMI was trading at $3.27 with a previous close of $13.20investing.com. This represents a collapse of roughly 75%
24 October 2025
·
General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

General Dynamics Stock Rockets to Record High on Blowout Q3 Results and Defense Windfall

Blowout Q3 Results and Rising Orders General Dynamics (NYSE: GD) stunned investors on Oct. 24, 2025, with a blowout third-quarter report. The defense and aerospace giant said Q3 revenue was $12.91 billion – about 10.6% higher than a year ago – beating the ~$12.57 billion analysts expectedbenzinga.com. GAAP earnings per share came in at $3.88, well above the $3.69 consensus estimatebenzinga.combenzinga.com. Operating income was $1.3 billion, and margins expanded by 20 basis points to 10.3%. Management highlighted exceptionally strong demand. “Each of our four segments grew earnings and backlog in the quarter, reflecting solid execution coupled with growing demand,” CEO Phebe Novakovic saidbenzinga.com.
24 October 2025
··
NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

NeurAxis (NRXS) Stock Skyrockets on First-Ever FDA Approval for GI Pain Device

Recent FDA Approval and Market Reaction NeurAxis’s Oct. 24, 2025 announcement of FDA 510(k) clearance for its PENFS device immediately grabbed market attention. The clearance authorizes use in adults (8 years and up) for functional abdominal pain associated with FD and nausea, a segment previously lacking any approved device treatmentinvesting.com. Investing.com and other outlets confirm this milestone — noting it’s “the first FDA clearance or approval” for an adult FD treatmentinvesting.com. In pre-market trading on Oct. 24, NRXS shares jumped (around +4% in early quotes) on the news, reflecting relief that FDA evidence support (from pediatric studies) could be extended
24 October 2025
·
Bond Yields Plunge on Cooling Inflation – Fed Cuts and Stock Rally in Play?

Bond Yields Plunge on Cooling Inflation – Fed Cuts and Stock Rally in Play?

The delayed September inflation report – pushed back by the U.S. government shutdown – turned out a bit cooler than expected, reaffirming the narrative that price pressures are easing. The Labor Department said headline CPI rose 0.3% in September (3.0% year-on-year), slightly under the 0.4%/3.1% that economists had forecast reuters.com. Core CPI (excluding food and energy) was up 3.0% YoY (vs 3.1% expected). Wall Street greeted the news calmly, since even at 3% inflation remains above the Fed’s 2% goal. What mattered more was that the softer reading bolsters confidence in near-term rate cuts: U.S. futures now fully price in
24 October 2025
··
Stocks Rocket on Cooling Inflation Data; Tech Stocks & Fed Speeches in Spotlight

Stocks Rocket on Cooling Inflation Data; Tech Stocks & Fed Speeches in Spotlight

Markets Rally as US Inflation Cools Wall Street surged on Oct. 24 after data showed US consumer prices rose less than forecast. The Labor Department’s CPI for September came in at 3.0% year-on-year (3.0% core) vs 3.1% expected xtb.com. That miss drove a rally in stock futures and sent the US dollar slightly lower, while gold and bonds rallied on renewed rate-cut hopes xtb.com reuters.com. As Reuters notes, the dollar index was steady (around 99.06) ahead of the report reuters.com, and traders now fully price a quarter-point Fed cut next week reuters.com reuters.com. “In midday trading, futures on the S&P 500
24 October 2025
··
Stocks Rally as U.S. Inflation Cools – Asia Joins Global Rally, Fed Cut Seen as Lock

Stocks Rally as U.S. Inflation Cools – Asia Joins Global Rally, Fed Cut Seen as Lock

Market Analysis: Friday’s tame CPI print soothed immediate rate-cut concerns and spurred a relief rally. Futures lifted all sectors, but tech/AI remains a focus. For example, AMD is near $235 after surging ~80% YTD on AI demand ts2.tech, and TSMC hovers near all-time highs (~$294) on chip demand ts2.tech. Mega-cap favorites carry “strong buy” sentiment – Microsoft, Amazon, Walmart and Broadcom top analyst picks ts2.tech. Health and energy also shine: Eli Lilly (~$935) is up on obesity-drug sales (analysts see ~20% more upside) ts2.tech, while refiners benefit from resilient oil prices. Expert Voices: “Valuations continue to be the best argument
24 October 2025
··
Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Billionaire Larry Ellison’s Fortune Plummets: Oracle Share Slump Wipes Out $24B

Stock Slide Hits Ellison’s Fortune Oracle’s spectacular AI-driven rally has turned choppy in recent days. After rocketing to all-time highs in September (briefly valuing Ellison’s stake at ~$393 B) reuters.com, profit-taking set in. The stock plunged about 7% on Oct. 17 (wiping ~$24B off Ellison’s wealth) and sank nearly 5% on Oct. 20 (erasing another ~$14B) financialexpress.com financialexpress.com. The selloff reflects a shift from “euphoria to caution,” as investors booked gains after Oracle’s string of AI contract announcements. By Oct. 23, ORCL closed around $280 ts2.tech – still roughly 70% above its January price, but down from its Sept. peak (~$345). Market watchers describe
24 October 2025
·
P&G Earnings Smash Estimates – Beauty Boom and Razors Fly Off Shelves in Q1

P&G Earnings Smash Estimates – Beauty Boom and Razors Fly Off Shelves in Q1

Procter & Gamble’s Q1 report beat expectations across the board. Revenue of $22.39 billion (vs. ~$22.17B forecast) and core EPS of $1.99 (vs. $1.90) both topped consensus marketscreener.com. In a statement, P&G credited resilient consumer demand for premium brands. For example, its beauty brands (Pantene, Olay, etc.) delivered roughly 6% organic growth finimize.com – a bright spot after weaker quarters. Grooming and personal care also held up; Bloomberg reports shoppers “brushed off price increases and snapped up the company’s Gillette razors and Secret deodorant,” underpinning the beat bloomberg.com. Overall volumes were flat, but higher pricing and cost savings boosted results.
24 October 2025
·
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Cloud and AI Drive Momentum Microsoft’s Azure cloud has been the standout. In FY2025 Azure revenue surpassed $75B, growing ~34% ts2.tech ts2.tech. Analysts note Azure continues to accelerate: in Q4 it was up ~39%, handily beating AWS and Google Cloud ts2.tech. That dominance is a key reason for the stock’s rally. As TechStock² (TS2.Tech) reports, Wall Street “still sees $600–$650 [over 12 months]” for MSFT ts2.tech. Indeed, banks like UBS and Bank of America recently reiterated Buy ratings and raised targets to ~$650 and $640, respectively insidermonkey.com ts2.tech. UBS “highlighted accelerating Azure growth trends” in its $650 target insidermonkey.com, and
24 October 2025
···
Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

As of Oct 24, 2025, RVPH shares trade around $0.57 investing.com, after a volatile October run (ranging roughly $0.26–$0.84). The stock has surged ~28% on Oct 23 (to $0.5675 markets.financialcontent.com) after a prior drop (–23% on Oct 8 benzinga.com). Recent catalysts include completion of a 1-year Phase 3 trial (brilaroxazine OLE) showing robust, sustained efficacy revivapharma.com, and plans for an FDA meeting in Q4 2025 toward a 2026 NDA revivapharma.com. Reviva also raised capital via equity offerings (~$10M in Q2 and ~$9M in Sept revivapharma.com revivapharma.com) to fund its CNS pipeline. Analysts remain extremely bullish – consensus is “Strong Buy”
24 October 2025
···
AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

In summary, AMD’s recent AI-driven surge has been fueled by heavyweight partnerships and robust demand, earning plaudits from executives and analysts alike. But the stock now sits at lofty valuations. Investors will be watching closely whether AMD can translate its new AI wins into sustained growth – success could justify prices well above today’s $235, while any misstep might curb the rally. As one analyst quipped, AMD is striving to be the “open, secure, and scalable” AI platform versus Nvidia’s closed box ts2.tech. Whether Wall Street’s bullish forecasts come true will depend on that bet paying off in the years
24 October 2025
··
Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta’s Oct. 24 announcement ignited optimism. According to the official press release, Anemocyte will incorporate Genenta’s clinically validated LVV plasmid DNA platform (originating from Naldini’s research) into its production pipeline investing.com. “By making our clinically validated LVV plasmid DNA technology platform available to Anemocyte and its clients, we are contributing to the reliable and scalable development of advanced therapy programs across the industry,” said CEO Pierluigi Paracchi investing.com. Anemocyte’s CEO Marco Ferrari added that the deal ensures customers have access to “a robust, well-established platform” for cutting-edge cell therapies investing.com. In effect, the partnership helps Genenta and its clients secure
24 October 2025
··
Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Stock Performance and Volatility Plug Power’s share price has been on a roller-coaster. After languishing around $1.50 in late summer 2025, the stock surged to a new 52-week high near $4.58 in early October marketbeat.com ts2.tech. By Oct. 23 it was trading around $2.88 marketbeat.com – still roughly double its summer lows. This sharp rise (≈170% in ~3 months ts2.tech) was driven partly by a classic short squeeze: nearly one-third of Plug’s float was sold short, forcing many bears to cover as positive news hit ts2.tech. Trading volume exploded on rally days (often 2–3× normal levels), reflecting feverish buying. In
24 October 2025
·
Ambev Stock Rallies to $2.21 – Analysts Pour Cold Water on Rally

Ambev Stock Rallies to $2.21 – Analysts Pour Cold Water on Rally

Market Snapshot: In recent days Ambev stock has been flat-to-up (≈+0.5%). On Oct 24 it traded near $2.20 reuters.com, close to its recent five-week low (~$2.18) and well below its 52-week high ($2.63). Year-to-date returns are modest (roughly +6–8%) reuters.com. Volumes have picked up ahead of Q3 earnings and on broader market swings. The slight uptick Oct 24 followed a series of choppy sessions, suggesting investors are watching for catalysts. Recent Developments: No major company-specific news broke in the past week. The focus is squarely on Ambev’s business trends and upcoming Q3 release (Oct 30). Q2 results (July 31) showed
24 October 2025
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

Stock Performance and Price In late October 2025, IonQ’s share price was around $60 after a tumultuous run. The stock peaked near $82 on Oct. 13 – a 75% year-to-date gain – but then fell back into the $60s ts2.tech ts2.tech. By Oct. 23 (the last full trading day), IonQ closed near $59.4 marketbeat.com. That week, Wednesday’s WSJ news and Thursday’s session saw large intraday swings: the price spiked to about $62.9 mid-day on Oct. 23 before settling around $59–60 marketbeat.com. Trading volume has been very heavy. For example, on Oct. 23 roughly 65 million shares traded hands – nearly triple the typical daily
24 October 2025
·
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

Stock Price and Recent Rally CrowdStrike’s stock has climbed sharply in October. After trading near $484 in mid-October, the share price jumped into the $520s by Oct 23 investing.com. For example, CRWD rose 3.91% on Oct 20 and 4.37% on Oct 23 investing.com, propelled by strong technical momentum and positive headlines. Over the past year the stock is up about 65% ts2.tech, vastly outpacing the S&P 500, as investors bet on its AI-driven growth. Technical indicators have also turned bullish: TipRanks noted on Oct 23 that CRWD’s 20-day exponential moving average (~$490) was well below the then-price (~$504), generating a
24 October 2025
·
Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir and Lumen Forge a New AI Infrastructure Alliance On Oct. 23, Palantir Technologies and Lumen Technologies unveiled a “multi-year, multi-million-dollar” strategic partnership to fuse Palantir’s AI/data platform with Lumen’s high-speed networking. According to the official release, the alliance will help enterprises “deploy AI faster and more securely” by combining Palantir’s Foundry/AIP software with Lumen’s next-generation “Connectivity Fabric” businesswire.com. Bloomberg News had reported Lumen would spend over $200 million on Palantir software aimmediahouse.com reuters.com, making this one of Palantir’s largest commercial deals to date. In a joint Fox Business interview, Palantir CEO Alex Karp stressed the national security stakes: “We’re in
24 October 2025
····
1 … 1,094 1,095 1,096 1,097 1,098 … 1,173

Stock Market Today

RBC stock heads into new week near C$233 after Canada jobs surprise

RBC stock heads into new week near C$233 after Canada jobs surprise

7 February 2026
Royal Bank of Canada shares closed Friday up 0.7% at C$232.72, trailing gains by other major Canadian banks. Canada’s main stock index surged 1.5% as metals rebounded. January jobs data showed a loss of 24,800 positions but a lower 6.5% unemployment rate. RBC’s Q1 earnings are due Feb. 26.
IHC stock price holds near 400 dirhams after Abu Dhabi group flags phishing emails

IHC stock price holds near 400 dirhams after Abu Dhabi group flags phishing emails

7 February 2026
International Holding Company PJSC warned investors of phishing scams using its name and logo, according to an ADX disclosure. IHC shares closed flat at 399.60 dirhams on Friday, trading in a narrow range with 237,109 shares changing hands. UAE equities ended the week slightly higher as traders watched Iran-U.S. talks and oil prices.
Go toTop